S-1 or Tegafur-Uracil in Treating Patients With Previously Treated Stage III or Stage IV Head and Neck Cancer
Condition(s):Head and Neck CancerLast Updated:May 15, 2013Unknown status
Hide Studies Not Open or Pending
Condition(s):Head and Neck CancerLast Updated:May 15, 2013Unknown status
Condition(s):Head and Neck CancerLast Updated:August 22, 2023Completed
Condition(s):Head and Neck Cancer; Radiation Toxicity; XerostomiaLast Updated:February 5, 2019Completed
Condition(s):Head and Neck Cancer; Infection; Oral ComplicationsLast Updated:December 15, 2016Completed
Condition(s):Head and Neck Cancer; Lung Cancer; Neurotoxicity; Ovarian CancerLast Updated:January 31, 2013Completed
Condition(s):Head and Neck CancerLast Updated:November 19, 2013Completed
Condition(s):Head and Neck CancerLast Updated:July 7, 2023Completed
Condition(s):Head and Neck CancerLast Updated:February 12, 2016Completed
Condition(s):Head and Neck CancerLast Updated:April 7, 2020Completed
Condition(s):Head and Neck CancerLast Updated:April 17, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.